Researchers at the University of Colorado Boulder have developed a groundbreaking handheld blood test that can deliver precise results in under an hour using a simple finger prick.

This innovative diagnostic tool employs biophotonics technology and a nanostructured metasurface chip to detect heart attack biomarkers, even in low concentrations.

The testing process utilizes sound waves to isolate microscopic biomarkers from blood samples, which are then analyzed with lasers for accurate readings.

The entire testing process takes less than 70 minutes, aiming to provide quick and precise diagnostic readings.

Lead author Peng Zheng emphasized the importance of early diagnosis in improving patient outcomes during heart attacks, as immediate medical intervention can significantly enhance survival rates.

This technology aims to democratize access to heart attack diagnostics, making it available in remote or underserved areas where advanced medical facilities are lacking.

Designed for use by physicians and first responders, this test could potentially be adapted for home use, enhancing accessibility for patients.

Heart attacks affect over 800,000 individuals annually in the United States, making early diagnosis critical yet challenging due to varying symptoms.

While the study serves as a proof-of-concept, further research is needed before the device can be widely implemented in medical settings.

Unlike previous claims from companies like Theranos, this device is based on systematic experiments and peer-reviewed research, ensuring its reliability.

Lead researcher Cooper Thome noted that while previous claims were unachievable, their work represents a significant step toward achieving accurate blood testing.

The study detailing this breakthrough was published in the journal Advanced Science and was funded by the National Institute of General Medical Sciences.